August 14, 2024
GWEST Corporation Limited (GWEST)
Unaudited financials for the first three months ended June 30, 2024:
GWEST Corporation Limited (GWEST) for the first three months ended June 30, 2024, reported a 14% increase in revenue totalling $56.18 million compared to $49.29 million in the corresponding three months last year.
Cost of Sales amounted to $47.50 million (2023: $26.29 million), this represents an increase of 81% year over year. Consequently, Gross Profit decreased by 62% to $8.67 million compared to $23.00 million for the first three months ended June 30, 2023.
Other gains or losses increase by 62% to close at $193,000 (2023: $119,000), while Administrative Expenses decrease by 36% from $30.47 million in 2023 to $19.39 million for the three months. Consequently, Operating Loss for the first quarter amounted to $10.53 million, a 43% increase relative to $7.35 million reported in 2023.
Finance Costs totalled $5.14 million, an 8% increase from the corresponding period last year. (2023: $4.77 million).
Net Loss for the three months amounted to $15.66 million, a 29% increase from the $12.12 million reported in 2023.
Consequently, Loss Per Share for the three months amounted to $0.03 (2023: LPS: $0.02). The twelve-month trailing LPS was $0.04, and the number of shares used in these calculations was 484,848,485. Notably, GWEST’s stock price closed the trading period on August 14, 2024, at a price of $0.91.
Balance Sheet Highlights
The company’s assets totalled $1.74 billion (2023: $1.42 billion). This increase in total assets was attributable to ‘Right of use assets’ which equated to $335.90 million for the first quarter of 2024 (2023: $26.53 million). Additionally, ‘Investment Property’ also contributed to the increase amounting to $723.68 million for the first quarter of 2024 (2023: $677.83 million).
Shareholder’s equity was $687.39 million (2023: $704.44 million), representing a book value per share of $1.42 (2023: $1.45).
Disclaimer:
Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.